PUBLISHER: The Business Research Company | PRODUCT CODE: 1945377
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945377
Ingestible biosensors are advanced medical devices that can be safely swallowed and move through the gastrointestinal tract, where they continuously track physiological parameters such as pH, temperature, pressure, or specific biomarkers. These sensors transmit real-time data to external devices, allowing physicians to evaluate digestive health, identify abnormalities, and tailor personalized treatment plans while reducing reliance on invasive procedures.
The main components of ingestible biosensors include capsule biosensors, pill biosensors, and others. Ingestible biosensors, or capsule biosensors, are swallowable devices equipped with sensors that measure physiological or biochemical conditions inside the gastrointestinal tract and transmit the information for diagnostic or therapeutic use. The various sensor types include temperature sensors, pH sensors, image sensors, and others. They are used in several applications, including medical diagnostics, drug delivery, patient monitoring, sports and fitness, and more, and serve end-users such as hospitals and clinics, research institutes, home care settings, and others.
Tariffs are impacting the ingestible biosensors market by increasing costs for microelectronics, imaging sensors, and wireless communication components. Asia-Pacific manufacturing regions and capsule biosensor segments are most impacted. While tariffs have slightly increased device pricing, they are encouraging localized assembly and innovation in biodegradable and cost-optimized ingestible sensor technologies.
The ingestible biosensors market research report is one of a series of new reports from The Business Research Company that provides ingestible biosensors market statistics, including ingestible biosensors industry global market size, regional shares, competitors with a ingestible biosensors market share, detailed ingestible biosensors market segments, market trends and opportunities, and any further data you may need to thrive in the ingestible biosensors industry. This ingestible biosensors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ingestible biosensors market size has grown rapidly in recent years. It will grow from $1.97 billion in 2025 to $2.18 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to limitations of traditional endoscopy, demand for non invasive diagnostics, advances in miniaturized sensors, rising gastrointestinal disorders, early capsule endoscopy adoption.
The ingestible biosensors market size is expected to see rapid growth in the next few years. It will grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to growth in personalized medicine, integration with mobile health platforms, expanding elderly population, technological improvements in data transmission, increased clinical adoption. Major trends in the forecast period include non invasive gastrointestinal monitoring, smart capsule based diagnostics, real time internal health tracking, personalized digestive health analysis, minimally invasive diagnostic alternatives.
The growing awareness of real-time monitoring is expected to drive the growth of the ingestible biosensors market. Real-time monitoring involves the continuous collection, analysis, and transmission of data as it is generated, enabling immediate health assessment and timely medical intervention. Awareness of real-time monitoring is rising due to the increasing focus on proactive healthcare management, as patients and healthcare providers recognize its value in enabling early detection of health issues and prompt medical responses. Ingestible biosensors facilitate real-time monitoring by transmitting physiological data from inside the body, allowing continuous tracking of parameters such as medication adherence, gastrointestinal activity, and biomarker levels for timely diagnosis and personalized treatment. For example, in October 2024, HealthArc, a US-based healthcare solutions provider, reported that approximately 30 million patients in the U.S. were using remote patient monitoring (RPM), with the number expected to increase to 70.6 million by the end of 2025. Additionally, 42 states have included RPM under Medicaid coverage, and more than 26% of Americans are anticipated to adopt it. Therefore, the increasing awareness of real-time monitoring is fueling the growth of the ingestible biosensors market.
Key companies operating in the ingestible biosensors market are focusing on developing innovative solutions, such as vitals-monitoring pills, to improve real-time health tracking and early disease detection. Vitals-monitoring pills are ingestible electronic capsules that track key physiological parameters, such as heart rate, and transmit real-time health data to external devices for monitoring and analysis. For instance, in November 2023, Celero Solutions Inc., a Canada-based information technology company, developed an ingestible electronic capsule, roughly the size of a multivitamin, capable of measuring heart and breathing rates from within the gastrointestinal tract. In a first-in-human trial involving ten participants, the device reliably detected breathing depressions, such as those occurring in obstructive sleep apnea and potentially in opioid overdose scenarios. The sensor uses an internal accelerometer and wireless transmission to capture vital-sign data and safely passes through the digestive tract without adverse effects. Researchers envision this technology being used for non-intrusive monitoring of respiratory status and potentially triggering interventions in high-risk patients.
In May 2025, imec VZW, a Belgium-based non-profit research and technology organization, partnered with OnePlanet Research Center to advance sustainable technology solutions by leveraging its expertise in nanoelectronics and digital innovations. This collaboration focuses on developing impactful and environmentally responsible healthcare solutions, including ingestible biosensors that enable real-time monitoring of vital signs and gastrointestinal health. OnePlanet Research Center, based in the Netherlands, is a multidisciplinary innovation and research institute specializing in advanced healthcare technologies.
Major companies operating in the ingestible biosensors market are Otsuka Holdings Co. Ltd., Proteus Digital Health Inc., etectRx Inc., CapsoVision Inc., IntroMedic Co. Ltd., BodyCap S.A.S., AnX Robotica Corporation, Atmo Biosciences Pty Ltd., Check-Cap Ltd., Chongqing Jinshan Science & Technology Group Co. Ltd., RF Co. Ltd., Biora Therapeutics Inc., EnteraSense Ltd., Lucid Medical Diagnostics Pvt. Ltd., Medisafe Capsule Technologies Ltd., Medtronic plc, Verily Life Sciences LLC, Olympus Corporation, JIFU Medical Technology Co. Ltd., Smart Medical Systems Ltd.
North America was the largest region in the ingestible biosensors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ingestible biosensors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ingestible biosensors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The ingestible biosensors market consists of sales of ingestible sensor devices, including capsule-based sensors, electronic pills, and smart drug delivery systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ingestible Biosensors Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ingestible biosensors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ingestible biosensors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ingestible biosensors market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.